Best of LinkedIn: Health Tech CW 02/ 03

Over the last two weeks, Health Tech conversations converged on one message. AI is moving from experimentation to operational design choices, while regulation, data governance, and workflow readiness decide what scales. Product momentum remained strong in imaging, cardiac care, and diagnostics, with Europe-focused access initiatives and selective ecosystem consolidation shaping the near-term agenda.

Date

January 19, 2026

Health Tech

Thomas Allgeyer

Methodology: Every two weeks we collect most relevant posts on LinkedIn for selected topics and create an overall summary only based on these posts. If you´re interested in the single posts behind, you can find them here: https://linktr.ee/thomasallgeyer. Have a great read!

Listen to our podcast

If you prefer listening, check out our podcast summarizing the most relevant insights from Health Tech Insights CW 02/ 03 :

From novelty to clinically anchored decision support

AI-powered triage systems are increasingly outperforming traditional decision trees, strengthening the case for AI at the front door of care
Strong patient pull for conversational health access is evident, with tens of millions already using general-purpose AI for medical queries
Patient empowerment narratives are tempered by unresolved concerns around accuracy, liability, and clinical accountability
Regulatory posture diverges, with Europe exercising tighter constraints while the US experiments under lighter oversight
2026 is framed as an execution year, where credibility depends on measurable clinical impact rather than AI promise

‍

Workflow, governance, and infrastructure emerge as the real scaling constraints

Broken clinical workflows are positioned as the primary failure mode, with AI amplifying inefficiencies if deployed prematurely
Governance gaps, particularly in Europe, are highlighted as risks for inequality and uneven care outcomes
Compliance and system integration are cited as dominant causes of pilot failure, especially in hospital environments
Nursing workflow redesign is framed as a high-leverage collaboration opportunity when clinicians are involved early
Lack of healthcare-grade privacy in consumer AI tools remains a structural barrier to patient-facing adoption

‍

Remote monitoring and virtual care mature, but economics decide impact

Wearables are positioned as continuous care-extension layers rather than standalone devices
Virtual COPD and chronic care models are viable only when equity, enrollment, and reimbursement are addressed alongside clinical design
Remote cardiology initiatives illustrate care models shifting beyond hospital-centric delivery
Burnout reduction and patient safety gains are increasingly used to justify ROI for AI-enabled monitoring
Preventive and everyday wellness use cases signal rising consumer demand shaping provider strategy

‍

MedTech and diagnostics remain central, with imaging and cardiac care leading

Foundation models such as MedGemma 1.5 are positioned as improving core medical AI capabilities across modalities
Diagnostic diffusion is increasingly procurement-driven, accelerating access in emerging and mid-scale markets
Cardiac innovation continues to dominate, spanning imaging, monitoring, and secure patient technologies
Infrastructure investments in diagnostics are framed as capacity expansion rather than incremental upgrades
Imaging and physiological assessment remain key anchors for AI-enabled clinical confidence

‍

Regulation and market access accelerate, with Alzheimer’s as a European priority

EU Medical Device Regulation reform is framed as a potential unlock for innovation velocity by 2026
Simplification efforts are positioned around faster patient access without compromising safety
Large-scale EU-funded Alzheimer’s initiatives signal coordinated investment across diagnosis and treatment
ACCESS-AD reinforces a pan-European approach to neurodegenerative disease innovation
Continued FDA clearances underscore steady regulatory throughput for robotics-enabled care pathways

‍

Ecosystem consolidation and orchestration gain momentum

Strategic acquisitions signal expansion into adjacent therapeutic categories rather than pure scale plays
Platform leaders emphasize product quality, AI integration, and experience over aggressive geographic growth
Ecosystem orchestration and community-building emerge as a strategic role for large health tech incumbents
Precision health narratives increasingly stress collaboration and delivery realism
AI-driven transformation in 2026 is framed as cost-aware, workforce-sensitive, and execution-led

‍

Subscribe to newsletter

Subscribe to receive the latest blog posts to your inbox every week.